Pregabalin Does Not Cause Left Anterior Flank (Loin) Pain
Pregabalin is not associated with left anterior flank pain or loin pain as a recognized adverse effect. The extensive clinical trial data and systematic reviews examining pregabalin's safety profile do not identify flank pain, loin pain, or localized unilateral abdominal/back pain as adverse events associated with this medication 1, 2, 3, 4.
Established Adverse Effect Profile of Pregabalin
The well-documented adverse effects of pregabalin are predominantly neurological and systemic, not localized musculoskeletal or visceral pain:
Most Common Adverse Effects (Dose-Dependent)
- Dizziness occurs in 23-46% of patients and is the most frequent reason for treatment discontinuation 2
- Somnolence affects 15-25% of patients, leading to discontinuation in approximately 3% 2
- Peripheral edema occurs in approximately 10% of patients, particularly problematic in elderly individuals 2, 5
- Weight gain is a recognized adverse effect, especially with elevated serum creatinine levels 5
Other Neurological Effects
- Ataxia, confusion, thinking abnormalities, tremor, abnormal gait, and amnesia occur less frequently but remain clinically significant 2
- Unsteadiness is predicted by advanced age rather than dose-dependent factors, with nonsteroidal anti-inflammatory drugs showing protective effects (OR 0.132) 5
Gastrointestinal Effects
Critical Clinical Reasoning
If a patient develops left anterior flank pain while taking pregabalin, investigate alternative etiologies rather than attributing it to the medication:
Differential Diagnosis to Consider
- Renal pathology: Nephrolithiasis, pyelonephritis, or renal infarction (pregabalin is 85-95% renally excreted unchanged, making renal function monitoring essential) 6, 7
- Musculoskeletal causes: Muscle strain, rib pathology, or referred pain from spine
- Gastrointestinal sources: Splenic pathology, colonic issues, or pancreatic tail involvement
- Vascular causes: Particularly in patients with peripheral edema from pregabalin
Important Monitoring Consideration
- Pregabalin requires mandatory dose reduction in renal impairment (50% reduction for creatinine clearance 30-60 mL/min, 75% for 15-30 mL/min, 85-90% for <15 mL/min) 6
- Elevated serum creatinine predicts both weight gain (OR 6.439) and edema (OR 6.912) 5
- If flank pain represents undiagnosed renal pathology, continued standard-dose pregabalin could lead to drug accumulation and increased adverse effects
Evidence Quality Assessment
The absence of flank pain as a pregabalin adverse effect is supported by:
- High-quality systematic reviews including 45 randomized controlled trials with 11,906 participants for neuropathic pain 4
- Cochrane reviews with comprehensive adverse event reporting from multiple large trials 3, 4
- American College of Physicians clinical practice guidelines based on systematic review of 12 antiseizure medication trials 1
- Specific adverse event prediction studies that identified factors for somnolence, unsteadiness, weight gain, and edema but not localized pain 5
The consistent absence of flank pain across thousands of participants in rigorous clinical trials provides high-quality evidence that this is not a pregabalin-related adverse effect.